Fenofibrate 200mg ( DrugBank: Fenofibrate )


1 disease
告示番号疾患名(ページ内リンク)臨床試験数
93原発性胆汁性胆管炎1

93. 原発性胆汁性胆管炎


臨床試験数 : 298 薬物数 : 252 - (DrugBank : 59) / 標的遺伝子数 : 35 - 標的パスウェイ数 : 115
No.TrialIDDate_
enrollment
Date_
registration
Public_titleScientific_titleConditionInterventionPrimary_
sponsor
Secondary_
sponsor
Recruitment_
Status
Inclusion_
agemin
Inclusion_
agemax
Inclusion_
gender
Target_
size
PhaseCountries
1NCT05749822
(ClinicalTrials.gov)
February 17, 202329/12/2022Fenofibrate for Compensated Cirrhosis Patients With Primary Biliary CholangitisFenofibrate Combined With Ursodeoxycholic Acid in Compensated Cirrhosis Patients With Primary Biliary Cholangitis Who Had an Inadequate Response to Ursodeoxycholic AcidPrimary Biliary CholangitisDrug: Fenofibrate 200mg;Drug: Placebo;Drug: UDCAXijing Hospital of Digestive DiseasesNULLRecruiting18 Years75 YearsAll104Phase 2/Phase 3China